Chronic LPSF/GQ-02 treatment attenuates inflammation and atherosclerosis development in LDLr-/- mice.
Silva AKSE, Gomes FODS, Santos Silva BD, Ribeiro EL, Oliveira AC, Araújo SMDR, de Lima IT, Oliveira AGV, Rudnicki M, Abdalla DSP, Lima MDCA, Pitta IDR, Peixoto CA.
Silva AKSE, et al. Among authors: ribeiro el.
Eur J Pharmacol. 2016 Nov 15;791:622-631. doi: 10.1016/j.ejphar.2016.09.037. Epub 2016 Sep 29.
Eur J Pharmacol. 2016.
PMID: 27693798